[go: up one dir, main page]

IN2014MN01513A - - Google Patents

Download PDF

Info

Publication number
IN2014MN01513A
IN2014MN01513A IN1513MUN2014A IN2014MN01513A IN 2014MN01513 A IN2014MN01513 A IN 2014MN01513A IN 1513MUN2014 A IN1513MUN2014 A IN 1513MUN2014A IN 2014MN01513 A IN2014MN01513 A IN 2014MN01513A
Authority
IN
India
Prior art keywords
subject
allergic
peptides
timothy grass
methods
Prior art date
Application number
Inventor
Alessandro Sette
Veronique Schulten
Howard Grey
Bjoern Peters
Jason Greenbaum
Original Assignee
Jolla Inst Allergy Immunolog
Alessandro Sette
Veronique Schulten
Howard Grey
Bjoern Peters
Jason Greenbaum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jolla Inst Allergy Immunolog, Alessandro Sette, Veronique Schulten, Howard Grey, Bjoern Peters, Jason Greenbaum filed Critical Jolla Inst Allergy Immunolog
Publication of IN2014MN01513A publication Critical patent/IN2014MN01513A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to Timothy Grass proteins and peptides subsequences portions homologues variants and derivatives thereof and methods and uses of Timothy Grass proteins and peptides. Methods include for example modulating an immune response; protecting a subject against or treating a subject for an allergic response allergic disorder or allergic disease; and inducing immunological tolerance to the allergen in a subject.
IN1513MUN2014 2012-02-07 2013-02-07 IN2014MN01513A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261596156P 2012-02-07 2012-02-07
US201261734886P 2012-12-07 2012-12-07
PCT/US2013/025213 WO2013119863A1 (en) 2012-02-07 2013-02-07 Timothy grass allergens and methods and uses for immune response modulation

Publications (1)

Publication Number Publication Date
IN2014MN01513A true IN2014MN01513A (en) 2015-09-11

Family

ID=48948025

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1513MUN2014 IN2014MN01513A (en) 2012-02-07 2013-02-07

Country Status (13)

Country Link
US (1) US10428124B2 (en)
EP (1) EP2812026A4 (en)
JP (1) JP2015513527A (en)
KR (1) KR20140129124A (en)
CN (1) CN104203277A (en)
AU (1) AU2013216993C1 (en)
BR (1) BR112014019504A2 (en)
CA (1) CA2864084A1 (en)
EA (1) EA201491481A1 (en)
HK (1) HK1204929A1 (en)
IN (1) IN2014MN01513A (en)
MX (1) MX2014009285A (en)
WO (1) WO2013119863A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015054231A1 (en) 2013-10-07 2015-04-16 La Jolla Institute For Allergy And Immunology Methods and uses for identifying responders to allergy therapy
WO2015054217A2 (en) 2013-10-07 2015-04-16 La Jolla Institute For Allergy And Immunology Methods and uses for reducing an allergic response in a subject
EP3071228A2 (en) 2013-11-20 2016-09-28 La Jolla Institute for Allergy and Immunology Pan pollen immunogens and methods and uses thereof for immune response modulation
WO2015077442A2 (en) 2013-11-20 2015-05-28 La Jolla Institute For Allergy And Immunology Grass pollen immunogens and methods and uses for immune response modulation
US10059751B2 (en) 2013-12-23 2018-08-28 Alk-Abelló A/S Peptide combinations and uses thereof in treating dust mite allergy
WO2015131053A1 (en) 2014-02-28 2015-09-03 Alk-Abelló A/S Polypeptides derived from phl p and methods and uses thereof for immune response modulation
JP6423889B2 (en) * 2014-10-07 2018-11-14 サイトリミック株式会社 HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using the same, immunity-inducing agent, and method for producing antigen-presenting cells
DK3269733T3 (en) 2015-03-09 2020-07-27 Cytlimic Inc PEPTIDE DERIVED FROM GPC3, PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF CANCER IN ITS USE, IMMUNITY INDICES AND METHOD OF PREPARING ANTIGEN PRESENTS
US10842848B2 (en) 2015-04-07 2020-11-24 Cytlimic Inc. Method for treating cancer by adminstering poly I:C and LAG-3-IgG fusion protein
AU2017259987B2 (en) * 2016-05-03 2023-10-19 Sqz Biotechnologies Company Intracellular delivery of biomolecules to induce tolerance
CN109982711A (en) 2016-10-11 2019-07-05 Cytlimic公司 Drug
CN119086940A (en) * 2017-04-28 2024-12-06 朋友股份有限公司 Antigens and epitopes of allergic reactions
AU2020391635A1 (en) * 2019-11-25 2022-05-12 The Regents Of The University Of California Antigenic neuron specific enolase peptides for diagnosing and treating autism
CN120349374B (en) * 2025-03-25 2025-10-10 长沙理工大学 Rice residue short peptide and application thereof in uric acid reduction

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214786B2 (en) * 2000-12-14 2007-05-08 Kovalic David K Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
AUPR775401A0 (en) 2001-09-18 2001-10-11 Monash University Novel Epitopes and Uses Thereof
ATE550349T1 (en) * 2002-06-25 2012-04-15 Merck Patent Gmbh DNA SEQUENCE AND RECOMBINANT PRODUCTION OF THE GRASS POLLEN ALLERGEN PHL P4
BRPI0313613B1 (en) * 2002-08-19 2016-06-07 Merck Patent Ges Mit Beschränkter Haftung variants of the major timothy grass phl p 1 allergen, their folding forms lm and hm, their uses and their preparation and purification processes, DNA molecule, recombinant DNA expression vector and its use, and pharmaceutical compositions
MXPA05005528A (en) 2002-11-26 2006-04-05 Alk Abello As Pharmaceutical allergen product.
AU2006204997B2 (en) 2005-01-12 2011-09-01 Monsanto Technology, Llc Genes and uses for plant improvement
US20090070897A1 (en) * 2006-01-12 2009-03-12 Goldman Barry S Genes and uses for plant improvement
ES2585407T3 (en) * 2008-02-01 2016-10-05 Murdoch Childrens Research Institute A method to induce tolerance to an allergen
EP2388268A1 (en) 2010-05-18 2011-11-23 Stallergenes S.A. Recombinant Der p 2 expressed in Pichia pastoris as a "natural-like" allergen for immunotherapy and diagnostic purposes
EA201390559A1 (en) 2010-10-15 2013-08-30 Альк-Абелло А/С SUPPRESSION OF IMMUNE RESPONSE BY THE TYPE OF HYPERSENSITIVITY BY NON-DOMINAL ANTIGEN, RECEIVED FROM THE MATERIAL OF SOURCE ALLERGENS
US20130216582A1 (en) 2010-10-15 2013-08-22 Alk-Abello A/S Suppression of a type 1 hypersensitivity immune response with an unrelated antigen
EP2831102A4 (en) * 2012-03-26 2015-12-02 Pronutria Inc NUTRIENT FRAGMENTS, NUTRIENT PROTEINS AND METHODS
DK2838556T3 (en) 2012-04-16 2017-04-10 Alk-Abelló As Plant profile polypeptides for use in non-specific allergy immunotherapy

Also Published As

Publication number Publication date
JP2015513527A (en) 2015-05-14
AU2013216993C1 (en) 2017-01-19
AU2013216993A1 (en) 2014-08-21
AU2013216993B2 (en) 2016-09-15
CN104203277A (en) 2014-12-10
BR112014019504A2 (en) 2017-06-27
EA201491481A1 (en) 2014-11-28
US20150023992A1 (en) 2015-01-22
KR20140129124A (en) 2014-11-06
CA2864084A1 (en) 2013-08-15
WO2013119863A1 (en) 2013-08-15
EP2812026A4 (en) 2016-04-27
US10428124B2 (en) 2019-10-01
MX2014009285A (en) 2015-02-04
HK1204929A1 (en) 2015-12-11
EP2812026A1 (en) 2014-12-17

Similar Documents

Publication Publication Date Title
IN2014MN01513A (en)
CA2863861A1 (en) Epitopes from allergen proteins and methods and uses for immune response modulation
MX2019011952A (en) Anti-garp protein and uses thereof.
WO2013106834A3 (en) Immunogenic wt-1 peptides and methods of use thereof
SG194755A1 (en) Pre-fusion rsv f antigens
EA201590451A1 (en) METHOD OF TREATING MELANOMA WITH THE USE OF VIRUS HERPES VIRUS AND INHIBITOR IMMUNE CONTROL POINT
SG11201505480SA (en) Amino acid and protein hydrolysate based formulas with a stable emulsion system
EA201790109A1 (en) TOLEROGENIC SYNTHETIC NANO-MEDIA DECREASING IMMUNE RESPONSE TO THERAPEUTIC PROTEINS
BR112013020500A8 (en) isolated, recombinant or purified antibody
BR112015013127A2 (en) immunotherapy with binding agents
MX348071B (en) Fc variants.
WO2011113019A3 (en) Ctla4 proteins and their uses
BR112016011025A2 (en) antibody polypeptides and their uses
IN2014CN04498A (en)
TR201905619T4 (en) Peptide carrier fusion proteins as allergy vaccines.
BR112013018742A2 (en) polypeptide transporter (s) and use to induce both therapies and prophylactic immune response
EP3087185A4 (en) Antibodies comprising c-terminal light chain polypeptide extensions and conjugates and methods of use thereof
WO2014204816A3 (en) Method for assessing protein identity and stability
MX2015012428A (en) Treating th2-mediated diseases by inhibition of bromodomain-comprising proteins brd7 and brd9.
PH12014502352A1 (en) Aqueous pharmaceutical composition containing a biologic therapeutic agent and guanidine or a guanidine derivative and an injection including the composition
WO2016131000A3 (en) Tolerance therapeutic for treating polypeptide induced allergy
BR112014011481A2 (en) collagen hydrolyzate and its use
PH12015501870B1 (en) Nutritional compositions containing a peptide component with adiponectin stimulating properties and uses thereof
BR112014028130A2 (en) HYDROchloride salt of a peptide, pharmaceutical composition, use of a hydrochloride salt, use of a pharmaceutical composition, and method of preventing or treating cat allergy
WO2013095091A3 (en) Rsv g protein specific antibodies